Format

Send to

Choose Destination
J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):441-444. doi: 10.1136/jnnp-2017-316519. Epub 2017 Aug 17.

Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis.

Author information

1
Università Vita-Salute San Raffaele, Milan, Italy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
2
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
3
Department of Neurosurgery and Gamma Knife Radiosurgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
4
Neuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
5
Department of Ophthalmology, Fondazione IRCCS Istituto Auxologico Italiano, Neuro-Ophthalmology Service, Milan, Italy.
6
Department of Laboratory Medicine, IRCCS San Raffaele Institute, Milan, Italy.
7
Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
8
Department of Otorhinolaryngology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
9
Unit of Medicine and Advanced Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
#
Contributed equally

KEYWORDS:

IgG4 - IgG4-related disease – Pachymeningitis – Rituximab - Intrathecal

PMID:
28819060
DOI:
10.1136/jnnp-2017-316519
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center